Human Skin Equivalents Expressing Exogenous Polypeptides

Abstract

The present invention relates generally to compositions for wound closure. More specifically, the present invention provides human skin equivalents engineered to express exogenous polypeptides (e.g., antimicrobial polypeptides and keratinocyte growth factor 2) and compositions and methods for making human skin equivalents engineered to express exogenous polypeptides. In addition, the present invention provides methods for treatment of wounds with human skin equivalents engineered to express exogenous polypeptides.


Claims
CPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Jan 10, 2012
  • Application: Jan 20, 2010
    US US 69016010 A
  • Priority: Jan 20, 2010
    US US 69016010 A
  • Priority: Jul 30, 2004
    US US 90911904 A
  • Priority: Aug 8, 2003
    US US 49366403 P
  • Priority: Aug 1, 2003
    US US 49186903 P

Download Citation


Sign in to the Lens

Feedback